Dunhill Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Dunhill Financial's BMY Position: Q2 2026 in Review
Dunhill Financial reduced its Bristol-Myers Squibb (BMY) stake by 0.11% in Q2 2026, selling an estimated $115 and leaving 1,889 shares worth $109K. The position accounts for 0.02% of the portfolio, ranked #213.
Dunhill Financial first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $115K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Dunhill Financial held 1,889 shares of Bristol-Myers Squibb worth $109K as of Q2 2026.
- Dunhill Financial sold 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
- Bristol-Myers Squibb made up 0.02% of Dunhill Financial's portfolio in Q2 2026, its #213 holding.
- Dunhill Financial first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Dunhill Financial's Bristol-Myers Squibb position peaked at $115K in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.